AzTrials
AzTrials

Obesity PreventionHealthyW8NCT07011368

Empowering Healthy Lifestyle Personalised Intervention to Prevent and Control Obesity: The HealthyW8 Project

A study testing Intervention Group in people with Obesity Prevention and Obesity and Overweight, run by Fundació d'investigació Sanitària de les Illes Balears at 13 sites in 8 countries.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record

Search all trials

Trial summary

The goal of the HealthyW8 study (an intervention study) is: To assess the usefulness and effects of a digital-based healthy lifestyle recommender system (HRLS) on the prevention of obesity in the following propulations: schoolchildren (5-10 y) and their parents, young adults (18-25 y) and elders (>65 y). Read more about this study

Who is it for?
Ages 7 years and olderHealthy volunteers can take part
What is being tested?
Intervention Group
Could I receive a placebo?
No, everyone receives an active treatment
How many people
2,720 participants
Where
13 sitesin 8 countries
Study dates
1 Jul 2025to 30 Jun 2028
Phase
Interventional

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 7 years and older
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • Overweight (BMI between 25-30 kg/m^2)
  • To have a smart phone

Who cannot join

  • Individuals with manifest chronic diseases
  • Individuals with cognitive diseases
  • Individuas not able to lead an independent life

Trial locations and contacts

13 sites in 8 countries. Contact the study team or a site near you to ask about taking part.

Josep A Tur, PhD contact

+34971173146

pep.tur@uib.es

13 sites in 8 countries

Spain3 sites
  • Centre de Recerca En Economia I Desenvolupament Agroalimentari-Upc-Irta

    Castelldefels, 08860

  • Fundacio Institut D'Investigacio Sanitaria Illes Balears (Idisba)

    Palma de Mallorca, Balearic Islands, 07122

  • Centro de Investigacion Y Tecnologia Agroalimentaria de Aragon

    Zaragoza, 50059

Other trials in Spain

Bulgaria2 sites
  • Virtech Ood

    Sofia, 1784

  • Regional Cluster North-East

    Varna, 9002

Other trials in Bulgaria

Germany2 sites
  • Leibniz-Institut Fur Praventionsforschung Und Epidemiologie - Bips Gmbh

    Bremen, 28359

  • Deutsches Forschungszentrum Fur Kunstliche Intelligenz Gmbh

    Kaiserslautern, 67663

Other trials in Germany

Portugal2 sites
  • Universidade de Coimbra

    Coimbra, 3004-531

  • Universidade de Evora

    Evora, 7000 803

Other trials in Portugal

Denmark1 site
  • Danmarks Tekniske Universitet

    Kongens Lyngby, 2800

Other trials in Denmark

Italy1 site
  • Universita Degli Studi Di Scienze Gastronomiche

    Bra, 12042

Other trials in Italy

Luxembourg1 site
  • Luxembourg Institute of Health

    Luxembourg, 1526

Other trials in Luxembourg

Netherlands1 site
  • Technische Universiteit Eindhoven

    Eindhoven, 5612 AE

Other trials in Netherlands

About this study

Official title: Empowering Healthy Lifestyle Behaviour Through Personalized Intervention Portfolios to Prevent and Control Obesity During Vulnerable Stages of Life: The HealthyW8 Project.

The goal of the HealthyW8 study (an intervention study) is:

To assess the usefulness and effects of a digital-based healthy lifestyle recommender system (HRLS) on the prevention of obesity in the following propulations: schoolchildren (5-10 y) and their parents, young adults (18-25 y) and elders (>65 y).

Read more

The main questions it aims to answer are:

Outcome 1: To select and validate a tool-assisted 3-mo intervention (mostly digital) by iteratively testing the HLRS on reducing risk of overweight/obesity among the described age groups.

Outcome 2: To assess the effect of 1-y interventions (mostly digital) with the HLRS described and further iteratively improved previously (outcome 1) on reducing risk of overweight/obesity at described ages.

Researchers will compare the intervention group before the intervention (baseline) and after it (3-mo intervention trial), or control group (standard care) vs. Intervention group (1-y intervention) to see changes on changes in overweight/obesity, and related parameters (body composition and biomarkers).

Participants will follow the HLRS recommendations (meal plans, physical activity and sleep pattern measures and recommendations, assessment of behavioural/psychological aspects, and motivational features through digital devices), which will be assessed by means of measurement of body weight, body composition, and biomarkers.

Read the detailed description

HealthyW8 will enhance early screening and prevention of obesity by making the scientific and technological breakthroughs necessary to support evidence-based clinical, environmental and policy-level decisions, while also directly empowering citizens to adopt healthy and sustainable lifestyle behaviours in a "push-pull" approach.

HealthyW8 will step up primary obesity prevention efforts across Europe, endowing them with a multi-disciplinary portfolio approach, i.e. a set of selective multi-component interventions that combine a large set of interventions and implementation options, focussing on diet, physical activity (PA), and psycho-emotional aspects.

The current approach considers obesity as a multifactorial phenomenon, necessitating a holistic, systemic approach accounting for the complexity of individual, interpersonal, organisational, community and public policy levels, as mutually reinforcing and supportive systems.

The attention will be focused on pivotal situations of transitions in the life-trajectory of individuals, which pose an elevated risk to progress from healthy weight to overweight and obesity, i.e. windows of opportunity to reduce the risk of developing obesity where the impact will have most leverage.

HealthyW8 targets vulnerable populations where transitional changes of lifestyle appear to be dominant: primary schoolchildren (5-12y, with active parent involvement), young adults (18-25y), and the elderly (>65y).

A central pillar of the current multiportfolio approach and intervention strategy will be a healthy lifestyle recommender solution (HLRS). Despite many apps on the market today that propose changes in dietary behaviour/PA, overweight and obesity are still on the rise across Europe. They failed to engage citizens with low interest in healthy lifestyle patterns and suffer from prominent limitations that HealthyW8 will address by developing the HLRS as a core element of our adapted intervention strategy and appropriate intervention tools.

Interventions' acceptability and feasibility to key stakeholders will be ensured by a participatory design approach, allowing stakeholders to influence from the outset their design \& development and integrate the needs of the target groups. The obesity prevention potential of interventions and/or their implementation strategies will be evaluated in over a dozen multicentre pilots (<3 months) and long-term (12 months) randomised control trials (RCTs). In parallel, it will collect user feedback on feasibility, acceptability and needs, allowing researchers to respond in real-time to problems/deviations and to capture context-related factors of success/failure.

Applying SMART criteria, HealthyW8 will achieve the following objectives:

  1. Expand understanding of the biological causes underlying obesogenic trends \& interactions with crosscutting environmental, behavioural \& policy factors to propose evidence-based effective obesity prevention strategies.
  2. Develop user-centred portfolio interventions to enhance the impact on lifestyle changes in an efficient, synergistic, long-lasting \& sustainable way.
  3. Iteratively optimise the intervention strategies involving vulnerable populations/those undergoing transitions to maximise impact.
  4. Leverage findings to EU stakeholders \& foster the multilevel uptake of solutions \& strategies.

Accordingly, multi-disciplinary portfolios of interventions adaptable to the targeted populations, and further to the individual (anthropometry, general health aspects, inflammation, oxidative stress, epigenetics, omics, microbiota, dietary \& general consulting, healthy lifestyle recommender solutions - HLRS, Human Digital Twin - HDT, policies recommendations, Open Stakeholder Pltform - OSP) will be developed. The focus on primary prevention, specifically the progression from healthy weight to overweight/obese, will allow targeting a broader population with a better cost/benefit ratio than secondary/tertiary preventions, though anticipating that the current portfolio approach and HLRS are adaptable to treatment scenarios also.

After an inventory of best practises \& relevant levers for overweight/obesity prevention \& management existing literature evidence will be synthesised. A system map for obesity prevention for the different targeted vulnerable groups and for the HDT. Via scoping, systematic and (umbrella-) reviews/meta-analyses, main drivers of the obesogenic environment will be highlighted.

These findings will be integrated in a multi-actor participatory design approach (Design Thinking, DT) into the development of the HLRS and of the HDT.

Implementation of pilot trials (<3 month; n=30 for each age group: primary schoolchildren (5-12y, with active parent involvement), young adults (18-25y), and the elderly (>65y) will be applied to validate the selected tool-assisted interventions by testing the HLRS and other health intervention strategies \& tools. Outcomes will lead to iterative tool development and a roadmap for larger long-term intervention studies.

Long term RCTs (12 months) with the same population groups will be conducted (n=55 per age group), compared vs. controls (n=55 per age group; receiving standard recommendations).

Populations will be replicated several times, participants longitudinally followed, and outcomes collected including: a) eating patterns (FFQs); b) markers related to obesity and comorbidities; c) lifestyle and cognitive aspects, psycho-emotional well-being (Emotional Guidance Scale encompassing e.g. joy, appreciation, freedom, empowerment, despair, fear); d) technological acceptance and usability (Mobile Application Rating Scale). Hence, we will apply a biopsychosocial understanding of obesity, integrating physiological, psychosocial, and contextual factors into one coherent model. Many markers/measures will be identical between countries/populations (core-endpoints), some different due to local/population-required adaptations.

Main outcome will be to assess the effect of 1 y interventions with the HLRS described and further iteratively improved in Pilot studies on reducing risk of overweight/obesity at various life-stages. Secondary objectives will be to assess the effect of interventions on body composition and metabolic and other parameters.

Being tested
Intervention Group
Keywords
Healthy lifestyle recommender system, digital empowerment, health literacy, personalised prevention, pre-obesity biomarkers, mHealth, Human Digital Twin, behavior change techniques, physical activity
Medical subject headings
Obesity, Overweight, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Intervention GroupBehavioural

    Healthy Lifestyle Recommender Solution (HLRS) will be developed as intervention tool for the trials. It integrates tools (mostly digital): a meal recommender to propose balanced and individually adapted meal plans, physical activity and sleep pattern measures and recommendations, assessment of behavioural/psychological aspects, and motivational features for sustained engagement and adherence.

    Within our multi-disciplinary portfolio approach, a set of predominantly eHealth solutions applied during the intervention trials for overweight/obesity prevention, developed in a participatory design approach with relevant stakeholders. This will include the HLRS, thus combining motivational features (nudging, gamification), targeted psychological support, dietary and physical activity advice, though also additional recommendations (healthy eating guidelines...) or education materials will be provided.

    Intervention trials/studies.

Study groups in NCT07011368
Study groupRoleWhat they receive
School-children (including families)ExperimentalHLRS intervention on 5-12 year-old school-children (including families) adapted to the countries in which they will be deployed (e.g.: adaptation to cultural food habits, translation into national languages).
Receives: Behavioral: Intervention Group
Young adultsExperimentalHLRS intervention on 18-25-year-old young adults adapted to the countries in which they will be deployed (e.g.: adaptation to cultural food habits, translation into national languages).
Receives: Behavioral: Intervention Group
Elderly peopleExperimentalHLRS intervention on >65-year-old elderly people adapted to the countries in which they will be deployed (e.g.: adaptation to cultural food habits, translation into national languages).
Receives: Behavioral: Intervention Group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in BMI

    The Primary Outcome (to be measured every 3 months) will be the change of BMI (kg/m^2) measuring body weight in kilograms and height in meters^2 as combined to obtain BMI data (kg/m^2) after the 12-month intervention of healthy lifestyle recommender solutions (HLRS) in the selected age groups (5-12 y.o. children and families; 18-25 y.o. young adults; and >65 y.o. elderly people).

    Measured: Baseline and every 3 months up to 12 months

Secondary outcomes (2)
  1. Change of visceral body fat

    The Secondary Outcome (to be measured every 3 months) will be the change of visceral body fat measuring body fat in kilograms and in percentage of body weight after the 12-month intervention of healthy lifestyle recommender solutions (HLRS) in the selected age groups (5-12 y.o. children and families; 18-25 y.o. young adults; and >65 y.o. elderly people).

    Measured: Baseline and every 3 months up to 12 months

  2. Body composition and biomarkers

    Other Secondary outcomes will be several biological markers measured every 6 months:

    • lipidic profile (cholesterol, LDL-c, HDL-C, triglycerides): mg/dL
    • glycidic profile (fasting blood glucose, HbA1C, insulin): mg/dL
    • inflammatory biomarkers (CRP, IL-1b/6/8, TNFa)
    • oxidative stress biomarkers (F2-isoprostanes, malondialdehyde): ng/mL
    • nutrition related markers: vitamin E, total carotenoids, total phenolics, sodium in urine: ng/dL
    • gut microbiome analyses (16S rRNA): assessment of bacterial species

    Measured: Baseline and every 6 months up to 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Jun 2025
  2. Study start1 Jul 2025 (estimated)
  3. Primary completion15 Jul 2025 (estimated)
  4. Study completion30 Jun 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
Intervention: 1. Pilot studies: Main objective is to validate the selected tool-assisted interventions by iteratively testing the HLRS and other health intervention tools among different end-user groups within different contexts (e.g. cultural, economic, social, physical). Pilot trials (\<3 months; n=30 per each age group: children, young adults, and elders) will assess their efficacy considering psychological/emotional states, adherence to dietary suggestions, technology acceptance, efficacy of nudges/gamification, user-friendliness of the tools, and actual usage and engagement. Outcomes will provide feedback for HLRS, including input for the HDT, and a roadmap for long-term intervention studies. 2. Long-trials: Main objective is to assess the effect of 1-y interventions with the HLRS described and further iteratively improved in Pilot trial on reducing risk of overweight/obesity at described life-stages n=55 per control \& intervention group, and described ages).
Masking
None (open label)
Enrolment
2,720 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07011368
Sponsor's protocol ID
HealthyW8-Pilot-and-Long-Trial
Other IDs
101080645
Acronym
HealthyW8
Status last verified
Apr 2025
First submitted
7 Apr 2025
Last updated
1 Jul 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: There are restrictions on the availability of data for this trial, due to the signed consent agreements around data sharing, which only allow access to external re-searchers for studies following the project purposes. Researchers wishing to access the trial data used in this study can make a request to pep.tur@uib.es

Publications

  • Vahid F, Dessenne C, Tur JA, Bouzas C, Devaux Y, Malisoux L, Monserrat-Mesquida M, Sureda A, Desai MS, Turner JD, Lamy E, Perez-Jimenez M, Ravn-Haren G, Andersen R, Forberger S, Nagrani R, Ouzzahra Y, Fontefrancesco MF, Onorati MG, Bonetti GG, de-Magistris T, Bohn T. Multicomponent (bio)markers for obesity risk prediction: a scoping review protocol. BMJ Open. 2024 Mar 8;14(3):e083558. doi: 10.1136/bmjopen-2023-083558.

    PubMed 38458803
  • Vahid F, Loyola-Leyva A, Bouzas C, Tur JA, Ivanova Y, Doychinov B, Nikolov R, Chikalanov A, De Magistris T, Halimi J, Forberger S, Stahl C, Evers S, Devaux Y, Malisoux L, Mendon P, Celebic A, Vaillant M, Gantenbein M, Skhiri L, Kallas Z, Garcia L, Bohn T; HealthyW8 consortium. Empowering healthy lifestyle behaviour through personalised intervention portfolios using a healthy lifestyle recommender system to prevent and control obesity in older adults: pilot study protocols from the HealthyW8 project. BMJ Open. 2026 Mar 25;16(3):e108771. doi: 10.1136/bmjopen-2025-108771.

    PubMed 41881526

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in